The 3-times higher tumour accumulation of [99mTc]Tc-labelled NGR-hPK5 compared to the wild-type molecule reflects the enhancement of tumour targeting capability induced by the incorporation of the NGR sequence. The gene discussed is RTN4R; the disease is neoplasm.